Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L Parviainen
Early Market Access for Pharmaceuticals in EU: What Is the Impact of Ema’s Accelerated Assessment Procedure?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
The Principle of Transparency and Access to Documents in the EU: For What, for Whom and of What?
SSRN Electronic Journal
Php316 - Exploring Biosimilar Market Access Considerations Across the Eu
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dilemmas in Regulation of the Market for Pharmaceuticals
Health Affairs
Medicine
Health Policy
Drug Repurposing in Pharmaceutical Industry and Its Impact on Market Access: Market Access Implications
Journal of Market Access & Health Policy
Pnd110 - Gene Therapy Products – Market Access Situation in Eu and in Slovakia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Accepted for the Impact Factor – What Is the Impact of Eurosurveillance?
Eurosurveillance
Environmental
Virology
Public Health
Epidemiology
Medicine
Occupational Health
Where Is Scientific Evidence Supporting EU Policy on BSE and Pharmaceuticals?
BMJ
What Is New in the EU Strategy in the Western Balkans?
Sovremennaya Evropa
Economics
International Relations
Econometrics
Political Science
Php319 - Mandatory Joint Clinical Assessment – What Is the Additional Insight From Eu-Nethta vs. Ema?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental